Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Escudier

Showing results (171-180 of 189) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|January 18, 2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaT E Hutson, R M Bukowski, B I Rini, et al.
British Journal of Cancer|June 29, 2013
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaborationA Bamias, K Tzannis, B Beuselinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Renal cancer]J-J Patard, H Baumert, K Bensalah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
The Journal of Urology|August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer CentersB Escudier, J P Droz, F Rolland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerL Derosa, M D Hellmann, M Spaziano, et al.
British Journal of Cancer|May 15, 2014
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trialB Escudier, M D Michaelson, R J Motzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trialM Staehler, R J Motzer, D J George, et al.
Pageof 19

Showing results (171-180 of 189) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|January 18, 2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaT E Hutson, R M Bukowski, B I Rini, et al.
British Journal of Cancer|June 29, 2013
Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaborationA Bamias, K Tzannis, B Beuselinck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysisS Bracarda, R Iacovelli, L Boni, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2014
[CCAFU Recommendations 2013: Renal cancer]J-J Patard, H Baumert, K Bensalah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 26, 2000
A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignanciesJ P Delord, E Raymond, M Chaouche, et al.
The Journal of Urology|August 21, 2002
Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer CentersB Escudier, J P Droz, F Rolland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerL Derosa, M D Hellmann, M Spaziano, et al.
British Journal of Cancer|May 15, 2014
Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trialB Escudier, M D Michaelson, R J Motzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2018
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trialM Staehler, R J Motzer, D J George, et al.
Pageof 19